The purpose of this study is to evaluate the safety and efficacy of the KLOX Biophotonic
System in patients with moderate to severe facial acne vulgaris using a split-face design
(treated hemiface vs untreated hemiface).
Device: KLOX Biophotonic System
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01584674
Ages eligible for Study
16 Years to 30 Years
Genders eligible for Study
Accepts Healthy Volunteers
Male or Female 16 - 30 years of age.
Fitzpatrick skin type I through IV.
Known medical history of active acne vulgaris for at least 6 months.
Moderate-to-severe facial acne, as defined by: Moderate is defined as a patient with an IGA of 3 with 20 to 40 inflammatory lesions
(papules and pustules) and no more than 1 nodule. Severe is defined as a patient with an IGA of 4 with a greater than 40 inflammatory lesions with the presence of no more than 2 nodules and/or inflammatory scaring type lesion. Also note that all patients should have a similar disease stage on both sides of their face.
The patient must have a clinical examination prior to treatment.
The patient must have signed the consent form.
The patient must be willing to return for follow-up visits.
Females of child bearing potential must have a negative pregnancy test result at baseline and both male and female patients must be willing to adhere to a birth control method.
Active skin infection on the face. Patient must not have active, localized or systemic infection.
Facial aesthetic procedure, including laser therapy and injectables within the last 6 months.
Enrollment in another acne study or other dermatological study using light therapy including tanning beds within 120 days of enrollment. Patients must not take part or intend to take part in another study liable to interfere with this study whatever the region of the body considered for 30 days prior to the study start and 30 days following completion of the study.
History of head and/or neck irradiation.
Use of a hormonal contraception is prohibited unless the birth control has been stable for the past 3 months. Note that patient that are presently taking or have taken in past 30 days Cyproterone Acetate + Ethinyl Estradiol (Diane-35) are not eligible for this study.
Any facial dermatological conditions that could hinder or interfere with clinical assessments.
Immunosuppression and/or cortisone therapy in the past 4 months.
Medications or supplements affecting coagulation.
Isotretinoin within the last 24 weeks.
Pregnant, breast-feeding or pregnancy planned during the trial.
History of facial nerve palsy or marked facial asymmetry.
History of neuromuscular disorder.
Prior facial surgery that alters subcutaneous tissues (e.g., rhytidectomy).
Use of non-acne topical medication that could interfere with study treatment.
Physical or psychiatric condition the investigator deems would preclude participation in the study. (e.g. Polycystic Ovary disease)
Unwillingness to refrain from excess sun exposure or tanning beds during the healing process -
All locations for NCT01584674
Attikon University General Hospital
Athens, Greece, 12462
Andreas Sygros Hospital
Athens, Greece, 16121
Thessaloniki, Greece, 56429
View full eligibility
Tris trial is registered with FDA with number: NCT01584674. The sponsor of the trial is KLOX Technologies Inc. and it is looking for 98 volunteers for the current phase.
Official trial title: A Prospective Clinical Trial Evaluating the Efficacy of the KLOX Biophotonic System (KLOX KLGA0105-01 and KLOX THERA LAMP) On Moderate to Severe Acne
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.